Document is current
Any future updates will be listed below
-
Authors
Dong, Mingze https://orcid.org/0000-0001-7367-6819
Su, David G. https://orcid.org/0000-0002-8693-612X
Kluger, Harriet
Fan, Rong https://orcid.org/0000-0001-7805-8059
Kluger, Yuval https://orcid.org/0000-0002-3035-071X
- License Information
-
More Information
Article History
Received: 15 January 2025
Accepted: 5 March 2025
First Online: 27 March 2025
Competing interests
: R.F. is co-founder of and scientific advisor to IsoPlexis, Singleton Biotechnologies, and AtlasXomics with financial interest. H.K. has received institutional research grants (to Yale University) from Merck, Bristol-Myers Squibb, Apexigen and personal fees from Iovance, Celldex, Merck, Bristol-Myers Squibb, Clinigen, Shionogi, Chemocentryx, Calithera, Signatero, Gigagen, GI reviewers, Pliant Therapeutics and Esai. The remaining authors declare no competing interests.
